These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18827195)

  • 21. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis.
    Hadley EA; Smillie FI; Turner MA; Custovic A; Woodcock A; Arkwright PD
    Clin Exp Immunol; 2005 Apr; 140(1):101-8. PubMed ID: 15762881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic effect of interleukin-12 on murine infection with Mycobacterium tuberculosis through modulating Th1 and Th2 cytokine balance].
    Zhang T; Kawakami K; Tang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):358-60. PubMed ID: 11778519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J; Stanford C; Grange J
    Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Zhang L; Jiang Y; Cui Z; Yang W; Yue L; Ma Y; Shi S; Wang C; Wang C; Qian A
    J Vet Sci; 2016 Dec; 17(4):505-513. PubMed ID: 27994210
    [No Abstract]   [Full Text] [Related]  

  • 29. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
    Okada M; Kita Y; Hashimoto S; Nakatani H; Nishimastu S; Kioka Y; Takami Y
    Hum Vaccin Immunother; 2017 Feb; 13(2):298-305. PubMed ID: 27960629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
    Kim SH; Cho D; Kim TS
    Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.
    Stanford J; Stanford C; Dlugovitzky D; Fiorenza G; Martinel-Lamas D; Selenscig D; Bogue C
    Immunotherapy; 2009 Nov; 1(6):933-47. PubMed ID: 20635912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.
    Fabre RA; Pérez TM; Aguilar LD; Rangel MJ; Estrada-Garcìa I; Hernández-Pando R; Estrada Parra S
    Clin Exp Immunol; 2004 May; 136(2):215-23. PubMed ID: 15086383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
    Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
    Maw WW; Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
    Butov DA; Efremenko YV; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Immunotherapy; 2013 Oct; 5(10):1047-54. PubMed ID: 24088075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV; Butov DA; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Hum Vaccin Immunother; 2013 Sep; 9(9):1852-6. PubMed ID: 23782489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.
    Skinner MA; Keen DL; Parlane NA; Yates GF; Buddle BM
    Tuberculosis (Edinb); 2002; 82(1):15-22. PubMed ID: 11914058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice with pulmonary tuberculosis treated with Mycobacterium vaccae develop strikingly enhanced recall gamma interferon responses to M. vaccae cell wall skeleton.
    Rodríguez-Güell E; Agustí G; Corominas M; Cardona PJ; Luquin M; Julián E
    Clin Vaccine Immunol; 2008 May; 15(5):893-6. PubMed ID: 18337379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.